Etzioni, R. et al. The case for early detection. Nat. Rev. Cancer 3, 243–252 (2003).
Hanash, S. M., Pitteri, S. J. & Faca, V. M. Mining the plasma proteome for cancer biomarkers. Nature 452, 571–579 (2008).
Blennow, K., Hampel, H., Weiner, M. & Zetterberg, H. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease. Nat. Rev. Neurol. 6, 131–144 (2010).
Rinschen, M. M., Ivanisevic, J., Giera, M. & Siuzdak, G. Identification of bioactive metabolites using activity metabolomics. Nat. Rev. Mol. Cell Biol. 20, 353–367 (2019).
Rochfort, S. Metabolomics reviewed: a new “omics” platform technology for systems biology and implications for natural products research. J. Nat. Prod. 68, 1813–1820 (2005).
Gomez-Casati, D. F., Zanor, M. I. & Busi, M. V. Metabolomics in plants and humans: applications in the prevention and diagnosis of diseases. Biomed. Res. Int. 2013, 792527 (2013).
Quack, M. Structure and dynamics of chiral molecules. Angew. Chem. Int. Ed. 28, 571–586 (1989).
Evans, P. R. An introduction to stereochemical restraints. Acta Crystallogr. D 63, 58–61 (2007).
Blackmond, D. G. Autocatalytic models for the origin of biological homochirality. Chem. Rev. 120, 4831–4847 (2019).
Plasson, R., Kondepudi, D. K., Bersini, H., Commeyras, A. & Asakura, K. Emergence of homochirality in far‐from‐equilibrium systems: mechanisms and role in prebiotic chemistry. Chirality 19, 589–600 (2007).
Shen, Q., Wang, L., Zhou, H., Yu, L.-S. & Zeng, S. Stereoselective binding of chiral drugs to plasma proteins. Acta Pharmacol. Sin. 34, 998–1006 (2013).
Müller, T. & Kohler, H.-P. Chirality of pollutants — effects on metabolism and fate. Appl. Microbiol. Biotechnol. 64, 300–316 (2004).
Armstrong, D. W., Zukowski, J., Ercal, N. & Gasper, M. Stereochemistry of pipecolic acid found in the urine and plasma of subjects with peroxisomal deficiencies. J. Pharm. Biomed. Anal. 11, 881–886 (1993).
Armstrong, D. W., Gasper, M., Lee, S. H., Zukowski, J. & Ercal, N. d-Amino acid levels in human physiological fluids. Chirality 5, 375–378 (1993).
Utembe, W. Chirality, a neglected physico-chemical property of nanomaterials? A mini-review on the occurrence and importance of chirality on their toxicity. Toxicol. Lett. 311, 58–65 (2019).
Abdulbagi, M., Wang, L., Siddig, O., Di, B. & Li, B. d-Amino acids and d-amino acid-containing peptides: potential disease biomarkers and therapeutic targets? Biomolecules 11, 1716 (2021).
Kranendijk, M., Struys, E. A., Salomons, G. S., Van der Knaap, M. S. & Jakobs, C. Progress in understanding 2-hydroxyglutaric acidurias. J. Inherit. Metab. Dis. 35, 571–587 (2012).
Talasniemi, J. P., Pennanen, S., Savolainen, H., Niskanen, L. & Liesivuori, J. Analytical investigation: assay of d-lactate in diabetic plasma and urine. Clin. Biochem. 41, 1099–1103 (2008).
Hashimoto, A., Oka, T. & Nishikawa, T. Extracellular concentration of endogenous free d-serine in the rat brain as revealed by in vivo microdialysis. Neuroscience 66, 635–643 (1995).
Hashimoto, A. et al. The presence of free d-serine in rat brain. FEBS Lett. 296, 33–36 (1992).
Mothet, J.-P. et al. d-Serine is an endogenous ligand for the glycine site of the N-methyl-d-aspartate receptor. Proc. Natl Acad. Sci. USA 97, 4926–4931 (2000).
Le Bail, M. et al. Identity of the NMDA receptor coagonist is synapse specific and developmentally regulated in the hippocampus. Proc. Natl Acad. Sci. USA 112, E204–E213 (2015).
Mothet, J. P., Le Bail, M. & Billard, J. M. Time and space profiling of NMDA receptor co‐agonist functions. J. Neurochem. 135, 210–225 (2015).
Dallérac, G. et al. Dopaminergic neuromodulation of prefrontal cortex activity requires the NMDA receptor coagonist d-serine. Proc. Natl Acad. Sci. USA 118, e2023750118 (2021).
Wolosker, H., Blackshaw, S. & Snyder, S. H. Serine racemase: a glial enzyme synthesizing d-serine to regulate glutamate-N-methyl-d-aspartate neurotransmission. Proc. Natl Acad. Sci. USA 96, 13409–13414 (1999).
Sason, H. et al. Asc-1 transporter regulation of synaptic activity via the tonic release of d-serine in the forebrain. Cereb. Cortex 27, 1573–1587 (2017).
Ivanov, A. D. & Mothet, J.-P. The plastic d-serine signaling pathway: sliding from neurons to glia and vice-versa. Neurosci. Lett. 689, 21–25 (2019).
Foltyn, V. N. et al. Serine racemase modulates intracellular d-serine levels through an α,β-elimination activity. J. Biol. Chem. 280, 1754–1763 (2005).
Schell, M. J., Molliver, M. E. & Snyder, S. H. d-Serine, an endogenous synaptic modulator: localization to astrocytes and glutamate-stimulated release. Proc. Natl Acad. Sci. USA 92, 3948–3952 (1995).
Perez, E. J. et al. Enhanced astrocytic d-serine underlies synaptic damage after traumatic brain injury. J. Clin. Invest. 127, 3114–3125 (2017).
Tapanes, S. A. et al. Inhibition of glial d‐serine release rescues synaptic damage after brain injury. Glia 70, 1133–1152 (2022).
Mustafa, A. K. et al. Serine racemase deletion protects against cerebral ischemia and excitotoxicity. J. Neurosci. Res. 30, 1413–1416 (2010).
Bendikov, I. et al. A CSF and postmortem brain study of d-serine metabolic parameters in schizophrenia. Schizophr. Res. 90, 41–51 (2007).
Wolosker, H. & Balu, D. T. d-Serine as the gatekeeper of NMDA receptor activity: implications for the pharmacologic management of anxiety disorders. Transl. Psychiatry 10, 1–10 (2020).
Klatte, K. et al. Impaired d-serine-mediated cotransmission mediates cognitive dysfunction in epilepsy. J. Neurosci. Res. 33, 13066–13080 (2013).
Beesley, S. et al. d-Serine mitigates cell loss associated with temporal lobe epilepsy. Nat. Commun. 11, 4966 (2020).
Mitchell, J. et al. Familial amyotrophic lateral sclerosis is associated with a mutation in d-amino acid oxidase. Proc. Natl Acad. Sci USA 107, 7556–7561 (2010).
Sasabe, J. et al. d-Amino acid oxidase controls motoneuron degeneration through d-serine. Proc. Natl Acad. Sci. USA 109, 627–632 (2012).
Spasova, K. & Fähling, M. d-Serine — A Useful Biomarker for Renal Injury? (Wiley, 2020).
Hamase, K., Morikawa, A. & Zaitsu, K. d-Amino acids in mammals and their diagnostic value. J. Chromatogr. B 781, 73–91 (2002).
Johnson, C. H., Ivanisevic, J. & Siuzdak, G. Metabolomics: beyond biomarkers and towards mechanisms. Nat. Rev. Mol. Cell Biol. 17, 451–459 (2016).
Schrimpe-Rutledge, A. C., Codreanu, S. G., Sherrod, S. D. & McLean, J. A. Untargeted metabolomics strategies — challenges and emerging directions. J. Am. Soc. Mass Spectrom. 27, 1897–1905 (2016).
Armstrong, D. Analysis of d-amino acids: relevance in human disease. LC GC N. Am. 40, 356–360 (2022).
Murtas, G. & Pollegioni, L. d-Amino acids as novel blood-based biomarkers. Curr. Med. Chem. 29, 4202–4215 (2022).
Paoletti, P., Bellone, C. & Zhou, Q. NMDA receptor subunit diversity: impact on receptor properties, synaptic plasticity and disease. Nat. Rev. Neurosci. 14, 383–400 (2013).
Hansen, K. B. et al. Structure, function, and allosteric modulation of NMDA receptors. J. Gen. Physiol. 150, 1081–1105 (2018).
Fuchs, S. A., Berger, R., Klomp, L. W. & De Koning, T. J. d-Amino acids in the central nervous system in health and disease. Mol. Genet. Metab. 85, 168–180 (2005).
Wong, J. M. et al. Postsynaptic serine racemase regulates NMDA receptor function. J. Neurosci. 40, 9564–9575 (2020).
留言 (0)